Innomar Strategies
Danielle Mason, BSc(Eng), PMP, is an accomplished professional in regulatory affairs and project management, currently serving as Associate Director of Regulatory Affairs at Innomar Strategies since November 2022, with prior experience as Sr Manager of Regulatory Affairs. Mason's career includes a tenure as Regulatory Affairs Manager at TPIreg, where responsibilities involved preparing regulatory submissions and leading project teams, as well as roles in earlier positions at TPIreg and Matrizyme Pharma that focused on compliance and product development. Mason's experience also encompasses project management and validation roles at Patheon and Novocol Pharmaceutical, as well as contributions to product development at GlaxoWellcome. Mason holds a Bachelor of Applied Science in Engineering from the University of Guelph.
Innomar Strategies
2 followers
Innomar Strategies, a part of AmerisourceBergen, is the leading patient support provider in the Canadian specialty biopharmaceutical market. We deliver end-to-end commercialization solutions to improve product access, increase supply chain efficiency and enhance patient care. Strategic consulting, patient support programs, nursing and clinical services, and specialty pharmacy and logistics are just a few of our key areas of specialization. We partner closely with manufacturers, healthcare providers, pharmacies and payers to ensure patients have consistent and reliable access to specialty medication. With our integrated approach and commitment to best-in-class care, Innomar Strategies helps navigate the patient journey to optimize health outcomes.